Great Point Partners LLC Cti Biopharma Corp Transaction History

Great Point Partners LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 15, 2019	SELL	$0.73 - $2.19 $15,651 - $46,955	-21,441 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$1.72 - $5.24 $2.61 Million - $7.94 Million	-1,515,579 Reduced 98.61%	21,441 $46,000
Q2 2018 Aug 14, 2018	SELL	$3.81 - $5.26 $571,500 - $789,000	-150,000 Reduced 8.89%	1,537,020 $7.65 Million
Q1 2018 May 14, 2018	BUY	$2.7 - $4.06 $4.55 Million - $6.85 Million	1,687,020 New	1,687,020 $0

Ticker CTIC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 114,385,000
Market Cap $1.04B
Description
CTI BioPharma Corp., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States. It offers VONJO (pacritinib), an investigational oral kinase inhibitor with specificity for JAK2, FLT3, IRAK1, and CSF1R for the treatment of adult patients w...

Get notified when there are updates to the investment portfolio of Great Point Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Great Point Partners LLC with notifications on news.